(Q38716949)

5 September 2017

1 reference

title

Clozapine: neuroleptic-induced EPS and tardive dyskinesia (English)

1 reference

5 September 2017

1 reference

Casey DE

1

1 reference

5 September 2017

1 January 1989

1 reference

5 September 2017

1 reference

5 September 2017

99 Suppl

1 reference

5 September 2017

S47-53

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00442559

5 September 2017

0 references

cites work

Clozapine in the treatment of tremor.

1 reference

12 December 2020

Apparent neuroleptic malignant syndrome with clozapine and lithium

1 reference

12 December 2020

Treatment of drug-induced exogenous psychosis in parkinsonism with clozapine and fluperlapine

1 reference

12 December 2020

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

12 December 2020

Phenothiazine-induced decompensation

1 reference

12 December 2020

Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine

1 reference

12 December 2020

Clozapine versus perphenazine: the value of the biochemical mode of action of neuroleptics in predicting their therapeutic activity

1 reference

12 December 2020

The risks and benefits of clozapine versus chlorpromazine

1 reference

12 December 2020

Clozapine in the treatment of newly admitted schizophrenic patients. A pilot study

1 reference

12 December 2020

Extrapyramidal symptoms following Clozapine therapy. Case report

1 reference

12 December 2020

Tolerability and therapeutic effect of clozapine. A retrospective investigation of 216 patients treated with clozapine for up to 12 years

1 reference

12 December 2020

Some methodological considerations for the clinical evaluation of neuroleptics--comparative effects of clozapine and haloperidol on schizophrenics

1 reference

12 December 2020

The trial use of clozapine for abnormal involuntary movement disorders

1 reference

12 December 2020

Double-blind comparison of clozapine with chlorpromazine in acute schizophrenic illness

1 reference

12 December 2020

Prediction of neuroleptic-induced dystonia

1 reference

12 December 2020

Tardive dyskinesia in the aged. Duration of treatment relationships.

1 reference

12 December 2020

Effects of clozapine, thioridazine, perlapine and haloperidol on the metabolism of the biogenic amines in the brain of the rat

1 reference

12 December 2020

Treatment outcome with clozapine in tardive dyskinesia, neuroleptic sensitivity, and treatment-resistant psychosis

1 reference

12 December 2020

Clozapine in tardive dyskinesia

1 reference

12 December 2020

Initial Anticholinergic Prophylaxis for Neuroleptic-Induced Extrapyramidal Syndromes

1 reference

12 December 2020

Clozapine (Leponex) compared with chlorpromazine: a double-blind evaluation of pharmacological and clinical properties.

1 reference

12 December 2020

An example of European multicenter trials: multispectral analysis of clozapine

1 reference

12 December 2020

An investigation of clozapine in the treatment of acute and chronic schizophrenia and gross behaviour disorders

1 reference

12 December 2020

1 reference

12 December 2020

Clozapine, chlorpromazine, and placebo in newly hospitalized, acutely schizophrenic patients: a controlled, double-blind comparison

1 reference

12 December 2020

Clozapine--a potential antipsychotic agent without extrapyramidal manifestations.

1 reference

12 December 2020

The pharmacology of 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine (clozapine)

1 reference

12 December 2020

Tardive dyskinesia during and following treatment with haloperidol, haloperidol + biperiden, thioridazine, and clozapine

1 reference

12 December 2020

Evaluation of side effects due to clozapine in long-term treatment of psychosis

1 reference

12 December 2020

Effect of clozapine in severe tardive dyskinesia: a case report

1 reference

12 December 2020

Clozapine and haloperidol in a single-blind cross-over trial: therapeutic and biochemical aspects in the treatment of schizophrenia

1 reference

12 December 2020

Clozapine, a novel major tranquilizer. Clinical experiences and pharmacotherapeutic hypotheses

1 reference

12 December 2020

Differential Effects of Classical and Atypical Antipsychotic Drugs on A9 and A10 Dopamine Neurons

1 reference

12 December 2020

Clozapine--a new antipsychotic agent.

1 reference

12 December 2020

Effects of clozapine on cerebral catecholaminergic neurone systems

1 reference

12 December 2020

Paradoxical response to dopamine agonists in tardive dyskinesia

1 reference

12 December 2020

Clozapine in the treatment of schizophrenic patients: an international multicenter trial.

1 reference

12 December 2020

Clozapine treatment of schizophrenic patients. Plasma concentration and coagulation factors

1 reference

12 December 2020

Extrapyramidal reactions and amine metabolites in cerebrospinal fluid during haloperidol and clozapine treatment of schizophrenic patients

1 reference

12 December 2020

Affective disorders and tardive dyskinesia

1 reference

12 December 2020

Anticholinergic properties of antipsychotic drugs and their relation to extrapyramidal side-effects

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00442559

1 reference

PubMed ID

2682732

Dimensions Publication ID

5 September 2017

0 references

1 reference

PubMed ID

2682732